ctrl K

Aspire BioPharma Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.34

-0.02 (-5.29%)

At close: May 02, 2025, 3:59 PM

0.38

11.59%

After-hours: May 02, 2025, 05:56 PM EDT

Aspire BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	3.63K	11.17K	38.00
Short-Term Investments	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	n/a	-4.97M	-4.9M
Receivables	n/a	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a
Total Current Assets	147.99K	46.17K	22.54K
Property-Plant & Equipment	n/a	n/a	n/a
Goodwill & Intangibles	n/a	4.97M	4.9M
Total Long-Term Assets	n/a	n/a	n/a
Total Assets	147.99K	46.17K	22.54K
Account Payables	310.22K	172.77K	122.73K
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	1.27M	360.64K	27.97K
Other Current Liabilities	111.03K	626.00	626.00
Total Current Liabilities	1.69M	534.03K	151.33K
Long-Term Debt	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	1.00
Total Long-Term Liabilities	n/a	n/a	1.00
Total Liabilities	1.69M	534.03K	151.33K
Total Debt	1.27M	360.64K	27.97K
Common Stock	22K	22K	221.5K
Retained Earnings	-2.78M	-1.47M	-1.11M
Comprehensive Income	n/a	n/a	n/a
Shareholders Equity	-1.54M	-487.86K	-128.79K
Total Investments	n/a	n/a	n/a